We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (FLAT-SUGAR)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01524705
First Posted: February 2, 2012
Last Update Posted: October 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Eli Lilly and Company
Sanofi
Bristol-Myers-Squibb/Astra-Zeneca
DexCom, Inc.
Bayer
Becton, Dickinson and Company
Medicomp
University of Texas
VA Office of Research and Development
Biomedical Research Institute of New Mexico
Information provided by (Responsible Party):
Jeff Probstfield, University of Washington
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):